HST
58
-4
MCHP
43
6
PFG
27
-3
PGR
59
5
IR
55
-3
WHR
70
-2
HAS
32
-5
PYPL
62
2
XEL
53
-2
TAP
60
2
AMG
54
-4
AIV
65
-6
SRE
47
2
CSX
44
-2
MAC
67
2
NDAQ
50
-6
ZION
57
-3
CMS
57
3
EXPD
37
-2
PNR
66
-3
HST
58
-4
MCHP
43
6
PFG
27
-3
PGR
59
5
IR
55
-3
WHR
70
-2
HAS
32
-5
PYPL
62
2
XEL
53
-2
TAP
60
2
AMG
54
-4
AIV
65
-6
SRE
47
2
CSX
44
-2
MAC
67
2
NDAQ
50
-6
ZION
57
-3
CMS
57
3
EXPD
37
-2
PNR
66
-3
Financhill
Back

Acelyrin Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Sell
20

SLRN
Acelyrin

Last Price:
3.23
Seasonality Move:
21.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Acelyrin Price Quote

$3.23

Acelyrin Key Stats

Sell
20
Acelyrin (SLRN) is a Sell
Day range:
$3.14 - $3.49
52-week range:
$3.18 - $8.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.67%
Volume:
785.8K
Avg. volume:
630.9K
1-year change:
-51.28%
Market cap:
$355.2M
Revenue:
$0
EPS:
$-2.46

How Much Does Acelyrin Make?

Data Unavailable

Is Acelyrin Growing As A Company?

Data Unavailable

Acelyrin Stock Price Performance

  • Did Acelyrin Stock Go Up Last Month?
    Acelyrin share price went down by -45.99% last month
  • Did SLRN's Share Price Rise Over The Last Year?
    SLRN share price fell by -51.28% over the past 1 year

What Is Acelyrin 52-Week High & Low?

  • What Is Acelyrin’s 52-Week High Share Price?
    Acelyrin has traded as high as $8.89 over the past 52 weeks
  • What Is Acelyrin’s 52-Week Low Share Price?
    Acelyrin has traded as low as $3.18 over the past 52 weeks

Acelyrin Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Acelyrin?

  • How Much Debt Does Acelyrin Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Acelyrin Have?
    Cash and short term investments quarterly total is $562.4M
  • What Is Acelyrin’s Book Value Per Share?
    Book value per share is 5.29

Is Acelyrin Cash Flow Positive?

  • What Is SLRN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$256M
  • What Is Acelyrin’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.1M
  • What Is Acelyrin’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $85M

Acelyrin Return On Invested Capital

Data Unavailable

Acelyrin Earnings Date & Stock Price

  • What Is Acelyrin's Stock Price Today?
    A single share of SLRN can be purchased today for 3.23
  • What Is Acelyrin’s Stock Symbol?
    Acelyrin trades on the nasdaq under the ticker symbol: SLRN
  • When Is Acelyrin’s Next Earnings Date?
    The next quarterly earnings date for Acelyrin is scheduled on March 28, 2025
  • When Is SLRN's next ex-dividend date?
    Acelyrin's next ex-dividend date is December 14, 2024
  • How To Buy Acelyrin Stock?
    You can buy Acelyrin shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Acelyrin Competitors

  • Who Are Acelyrin's Competitors?
    Below is a list of companies who compete with Acelyrin or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Bristol-Myers Squibb Co (BMY)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • Pfizer Inc (PFE)

Acelyrin Dividend Yield

  • What Is SLRN Dividend Yield?
    Acelyrin’s dividend yield currently is 0%
  • What Is Acelyrin’s Payout Ratio?
    Acelyrin’s payout ratio is 0%
  • When Did Acelyrin Last Pay A Dividend?
    The latest dividend pay date is December 14, 2024
  • What Is Acelyrin’s Dividend Per Share?
    Acelyrin pays a dividend of $0.00 per share

Acelyrin Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 32.71%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 10.17
Upside from Last Price: 214.76%

Major Shareholders

  • How many SLRN shares are owned by institutional investors?
    104.9M SLRN shares are owned by institutional investors
  • How many SLRN shares are owned by insiders?
    2.3M SLRN shares are owned by insiders